Pharmacological Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/04/5601-149-157$7.00
Pharmacol Rev 56:149-157, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brink, C.
Right arrow Articles by Yokomizo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brink, C.
Right arrow Articles by Yokomizo, T.

Article

International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor

Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo

Centre National de la Recherche Scientifique UMR 7131, Hôpital Broussais, Bâtiment Les Mariniers, Paris, France (C.B.); Unit for Experimental Asthma and Allergy, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.-E.D); Harvard Medical School, Brigham and Woman's Hospital, Boston, Massachussetts (J.M.D.); Department of Pharmacology, Merck & Co., West Point, Pennsylvania (J.F.E.); GlaxoSmithKline, King of Prussia, Pennsylvania (D.W.P.H.); Division of Molecular Pharmacology, Pharmacological Sciences, Milan, Italy (G.E.R.); Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia Research Laboratory, Brigham and Woman's Hospital/Harvard Medical School, Boston, Massachusetts (C.N.S.); and Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Bunkyo-Ko, Tokyo, Japan (T.S., T.Y.)

Abstract
I. Overview
II. Introduction
III. Biosynthesis of Oxoeicosanoids
    A. Cofactors for Oxoeicosanoid Formation
    B. Cellular Production of Oxoeicoanoids
IV. Nomenclature for Oxoeicosanoid Receptors
V. Molecular Characteristics of Oxoeicosanoid Receptors
VI. Significance of Oxoeicosanoid Receptors
VII. Conclusion
Abstract

Oxoeicosanoids are a family of biologically active arachidonic acid derivatives that have been intimately linked with cellular migration. These metabolites are not only potent chemotaxins but also elicit oxygen radical production as well as induce secretory events in different cells. The most potent native ligand reported is 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), and the cell membrane receptor activated has now been cloned. This receptor is distinct from those receptors activated by either the prostaglandins or the leukotrienes. The purpose of this review is to briefly summarize the molecular evidence and highlight the significance of this receptor. In addition, an official nomenclature for this oxoeicosanoid receptor is proposed.


Address correspondence to: Charles Brink, Researcher (CNRS CR-1), CNRS UMR 7131, Hôpital Broussais, Bâtiment Les Mariniers, 96, rue Didot, 75014 Paris, France. E-mail: charlesbrink{at}hotmail.com




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Cossette, P. Patel, J. R. Anumolu, S. Sivendran, G. J. Lee, S. Gravel, F. D. Graham, A. Lesimple, O. A. Mamer, J. Rokach, et al.
Human Neutrophils Convert the Sebum-derived Polyunsaturated Fatty Acid Sebaleic Acid to a Potent Granulocyte Chemoattractant
J. Biol. Chem., April 25, 2008; 283(17): 11234 - 11243.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement
Blood, March 1, 2006; 107(5): 2123 - 2130.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics